Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 7/2020

27.06.2020 | COVID-19 | Opinion Zur Zeit gratis

Installing oncofertility programs for common cancers in limited resource settings (Repro-Can-OPEN Study): An extrapolation during the global crisis of Coronavirus (COVID-19) pandemic

verfasst von: M. Salama, L. Ataman-Millhouse, M. Braham, K. Berjeb, M. Khrouf, J. K. Rodrigues, F. M. Reis, T. Cury- Silva, F. Sánchez, S. Romero, J. Smitz, L. Vásquez, M. Vega, F. Sobral, G. Terrado, M. G. Lombardi, A. Scarella, M. T. Bourlon, H. Verduzco-Aguirre, A. M. Sánchez, S. K. Adiga, P. Tholeti, K. S. Udupa, N. Mahajan, M. Patil, R. Dalvi, C. Venter, G. Demetriou, J. Geel, R. Quintana, G. Rodriguez, T. Quintana, L. Viale, M. Fraguglia, M. Coirini, Y. A. Remolina-Bonilla, J. A. R. Noguera, J. C. Velásquez, A. Suarez, G. D. Arango, J. I. D. Pineda, M. D. C. Aldecoa, M. Javed, H. Al Sufyan, N. Daniels, B. C. Oranye, A. A. Ogunmokun, K. I. Onwuzurigbo, C. J. Okereke, T. C. Whesu, T. K. Woodruff

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The state of limited resource settings that Coronavirus (COVID-19) pandemic has created globally should be taken seriously into account especially in healthcare sector. In oncofertility, patients should receive their fertility preservation treatments urgently even in limited resource settings before initiation of anticancer therapy. Therefore, it is very crucial to learn more about oncofertility practice in limited resource settings such as in developing countries that suffer often from shortage of healthcare services provided to young patients with cancer.

Methods

As an extrapolation during the global crisis of COVID-19 pandemic, we surveyed oncofertility centers from 14 developing countries (Egypt, Tunisia, Brazil, Peru, Panama, Mexico, Colombia, Guatemala, Argentina, Chile, Nigeria, South Africa, Saudi Arabia, and India). Survey questionnaire included questions on the availability and degree of utilization of fertility preservation options in case of childhood cancer, breast cancer, and blood cancer.

Results

All surveyed centers responded to all questions. Responses and their calculated oncofertility scores showed different domestic standards for oncofertility practice in case of childhood cancer, breast cancer, and blood cancer in the developing countries under limited resource settings.

Conclusions

Medical practice in limited resource settings has become a critical topic especially after the global crisis of COVID-19 pandemic. Understanding the resources necessary to provide oncofertility treatments is important until the current COVID-19 pandemic resolves. Lessons learned will be valuable to future potential worldwide disruptions due to infectious diseases or other global crises.
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.CrossRef Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.CrossRef
2.
Zurück zum Zitat Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.CrossRef Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.CrossRef
3.
Zurück zum Zitat Ataman LM, Rodrigues JK, Marinho RM, Caetano JP, Chehin MB, Alves da Motta EL, et al. Creating a Global Community of Practice for Oncofertility. J Glob Oncol. 2016;2(2):83–96. Ataman LM, Rodrigues JK, Marinho RM, Caetano JP, Chehin MB, Alves da Motta EL, et al. Creating a Global Community of Practice for Oncofertility. J Glob Oncol. 2016;2(2):83–96.
4.
Zurück zum Zitat Rashedi A, de Roo SF, Ataman L, Edmonds ME, Silva AA, Scarella A, et al. A survey of fertility preservation options available to cancer patients around the globe. J Glob Oncol. 2018;4:1–16. Rashedi A, de Roo SF, Ataman L, Edmonds ME, Silva AA, Scarella A, et al. A survey of fertility preservation options available to cancer patients around the globe. J Glob Oncol. 2018;4:1–16.
5.
Zurück zum Zitat Rashedi A, de Roo SF, Ataman L, Edmonds ME, Silva AA, Scarella A, et al. A survey of third-party parenting options associated with fertility preservation available to patients with cancer around the globe. J Glob Oncol. 2018;4:1–7. Rashedi A, de Roo SF, Ataman L, Edmonds ME, Silva AA, Scarella A, et al. A survey of third-party parenting options associated with fertility preservation available to patients with cancer around the globe. J Glob Oncol. 2018;4:1–7.
6.
Zurück zum Zitat Woodruff TK. The emergence of a new interdiscipline: oncofertility. Cancer Treat Res. 2007;138:3–11.CrossRef Woodruff TK. The emergence of a new interdiscipline: oncofertility. Cancer Treat Res. 2007;138:3–11.CrossRef
7.
Zurück zum Zitat Woodruff TK. Oncofertility: a grand collaboration between reproductive medicine and oncology. Reproduction. 2015;150(3):S1–10.CrossRef Woodruff TK. Oncofertility: a grand collaboration between reproductive medicine and oncology. Reproduction. 2015;150(3):S1–10.CrossRef
8.
Zurück zum Zitat Oncofertility Consortium - Northwestern University [Internet]. [cited 2020 1]. Available from <http://oncofertility.northwestern.edu/>: Oncofertility Consortium - Northwestern University [Internet]. [cited 2020 1]. Available from <http://​oncofertility.​northwestern.​edu/>:
9.
Zurück zum Zitat Practice Committee of the American Society for Reproductive Medicine (ASRM). Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022–33. Practice Committee of the American Society for Reproductive Medicine (ASRM). Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022–33.
10.
Zurück zum Zitat Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36(19):1994–2001. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36(19):1994–2001.
11.
Zurück zum Zitat von Wolff M, Andersen CY, Woodruff TK, Nawroth F. FertiPROTEKT, Oncofertility Consortium and the Danish Fertility-Preservation Networks - What Can We Learn From Their Experiences? Clin Med Insights Reprod Health. 2019;13:1179558119845865. von Wolff M, Andersen CY, Woodruff TK, Nawroth F. FertiPROTEKT, Oncofertility Consortium and the Danish Fertility-Preservation Networks - What Can We Learn From Their Experiences? Clin Med Insights Reprod Health. 2019;13:1179558119845865.
12.
Zurück zum Zitat Oncofertility Professional Engagement Network (OPEN) - Northwestern University [Internet]. [cited 2020 Apr 1]. Available from: <http://oncofertility.northwestern.edu/oncofertility-professional-engagement- network> Oncofertility Professional Engagement Network (OPEN) - Northwestern University [Internet]. [cited 2020 Apr 1]. Available from: <http://​oncofertility.​northwestern.​edu/​oncofertility-professional-engagement- network>
13.
Zurück zum Zitat Salama M, Ataman L, Taha T, Azmy O, Khrouf M, Braham M, et al. Building Oncofertility Core Competency in Developing Countries: Experience from Egypt, Tunisia, Brazil, Peru, and Panama. J Glob Oncol. 2018;4:1–11. Salama M, Ataman L, Taha T, Azmy O, Khrouf M, Braham M, et al. Building Oncofertility Core Competency in Developing Countries: Experience from Egypt, Tunisia, Brazil, Peru, and Panama. J Glob Oncol. 2018;4:1–11.
14.
Zurück zum Zitat Salama M, Ataman-Millhouse L, Sobral F, Terrado G, Scarella A, Bourlon MT, et al. Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network. J Glob Oncol. 2018;4:1–7. Salama M, Ataman-Millhouse L, Sobral F, Terrado G, Scarella A, Bourlon MT, et al. Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network. J Glob Oncol. 2018;4:1–7.
15.
Zurück zum Zitat Joint Statement from the Alliance for Fertility Preservation and the Oncofertility Consortium on Fertility Preservation for Patients Receiving Gonadotoxic Therapies During the COVID-19 Pandemic [Internet]. [cited 2020 Apr 1]. Available from: <http://oncofertility.northwestern.edu/news/joint-statement-alliance- fertility-preservation-and-oncofertility-consortium-fertility> Joint Statement from the Alliance for Fertility Preservation and the Oncofertility Consortium on Fertility Preservation for Patients Receiving Gonadotoxic Therapies During the COVID-19 Pandemic [Internet]. [cited 2020 Apr 1]. Available from: <http://​oncofertility.​northwestern.​edu/​news/​joint-statement-alliance- fertility-preservation-and-oncofertility-consortium-fertility>
16.
Zurück zum Zitat COVID-19 Task Force of the American Society for Reproductive Medicine (ASRM). [Internet]. [cited 2020 Apr 1]. Available from: <https://www.asrm.org/news-and-publications/covid-19/statements/patient- management-and-clinical-recommendations-during-the-coronavirus-covid-19-pandemic/> COVID-19 Task Force of the American Society for Reproductive Medicine (ASRM). [Internet]. [cited 2020 Apr 1]. Available from: <https://​www.​asrm.​org/​news-and-publications/​covid-19/​statements/​patient- management-and-clinical-recommendations-during-the-coronavirus-covid-19-pandemic/>
17.
Zurück zum Zitat Salama M, Isachenko V, Isachenko E, Rahimi G, Mallmann P. Updates in preserving reproductive potential of prepubertal girls with cancer: Systematic review. Crit Rev Oncol Hematol. 2016;103:10–21.CrossRef Salama M, Isachenko V, Isachenko E, Rahimi G, Mallmann P. Updates in preserving reproductive potential of prepubertal girls with cancer: Systematic review. Crit Rev Oncol Hematol. 2016;103:10–21.CrossRef
18.
Zurück zum Zitat Salama M, Woodruff TK. New advances in ovarian autotransplantation to restore fertility in cancer patients. Cancer Metastasis Rev. 2015;34(4):807–22. Salama M, Woodruff TK. New advances in ovarian autotransplantation to restore fertility in cancer patients. Cancer Metastasis Rev. 2015;34(4):807–22.
19.
Zurück zum Zitat Salama M, Woodruff TK. Anticancer treatments and female fertility: clinical concerns and role of oncologists in oncofertility practice. Expert Rev Anticancer Ther. 2017;17(8):687–92. Salama M, Woodruff TK. Anticancer treatments and female fertility: clinical concerns and role of oncologists in oncofertility practice. Expert Rev Anticancer Ther. 2017;17(8):687–92.
20.
Zurück zum Zitat Bourlon MT, Anazodo A, Woodruff TK, Segelov E. Oncofertility as a Universal Right and a Global Oncology Priority. JCO Glob Oncol. 2020;6:314–6.CrossRef Bourlon MT, Anazodo A, Woodruff TK, Segelov E. Oncofertility as a Universal Right and a Global Oncology Priority. JCO Glob Oncol. 2020;6:314–6.CrossRef
21.
Zurück zum Zitat Salama M, Woodruff TK. From bench to bedside: Current developments and future possibilities of artificial human ovary to restore fertility. Acta Obstet Gynecol Scand. 2019;98(5):659–64. Salama M, Woodruff TK. From bench to bedside: Current developments and future possibilities of artificial human ovary to restore fertility. Acta Obstet Gynecol Scand. 2019;98(5):659–64.
22.
Zurück zum Zitat Salama M, Isachenko V, Isachenko E, Rahimi G, Mallmann P. Advances in fertility preservation of female patients with hematological malignancies. Expert Rev Hematol. 2017;10(11):951–60. Salama M, Isachenko V, Isachenko E, Rahimi G, Mallmann P. Advances in fertility preservation of female patients with hematological malignancies. Expert Rev Hematol. 2017;10(11):951–60.
23.
Zurück zum Zitat Salama M, Anazodo A, Woodruff TK. Preserving fertility in female patients with hematological malignancies: A multidisciplinary oncofertility approach. Ann Oncol. 2019;30(11):1760–75. Salama M, Anazodo A, Woodruff TK. Preserving fertility in female patients with hematological malignancies: A multidisciplinary oncofertility approach. Ann Oncol. 2019;30(11):1760–75.
Metadaten
Titel
Installing oncofertility programs for common cancers in limited resource settings (Repro-Can-OPEN Study): An extrapolation during the global crisis of Coronavirus (COVID-19) pandemic
verfasst von
M. Salama
L. Ataman-Millhouse
M. Braham
K. Berjeb
M. Khrouf
J. K. Rodrigues
F. M. Reis
T. Cury- Silva
F. Sánchez
S. Romero
J. Smitz
L. Vásquez
M. Vega
F. Sobral
G. Terrado
M. G. Lombardi
A. Scarella
M. T. Bourlon
H. Verduzco-Aguirre
A. M. Sánchez
S. K. Adiga
P. Tholeti
K. S. Udupa
N. Mahajan
M. Patil
R. Dalvi
C. Venter
G. Demetriou
J. Geel
R. Quintana
G. Rodriguez
T. Quintana
L. Viale
M. Fraguglia
M. Coirini
Y. A. Remolina-Bonilla
J. A. R. Noguera
J. C. Velásquez
A. Suarez
G. D. Arango
J. I. D. Pineda
M. D. C. Aldecoa
M. Javed
H. Al Sufyan
N. Daniels
B. C. Oranye
A. A. Ogunmokun
K. I. Onwuzurigbo
C. J. Okereke
T. C. Whesu
T. K. Woodruff
Publikationsdatum
27.06.2020
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 7/2020
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-020-01821-7

Weitere Artikel der Ausgabe 7/2020

Journal of Assisted Reproduction and Genetics 7/2020 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.